Perspectives on the Pseudomonas aeruginosa Type III Secretion System Effector ExoU and Its Subversion of the Host Innate Immune Response to Infection.
Kierra S HardyMaxx H TessmerDara W FrankJonathon P AudiaPublished in: Toxins (2021)
Pseudomonas aeruginosa is an opportunistic, Gram-negative pathogen and an important cause of hospital acquired infections, especially in immunocompromised patients. Highly virulent P. aeruginosa strains use a type III secretion system (T3SS) to inject exoenzyme effectors directly into the cytoplasm of a target host cell. P. aeruginosa strains that express the T3SS effector, ExoU, associate with adverse outcomes in critically ill patients with pneumonia, owing to the ability of ExoU to rapidly damage host cell membranes and subvert the innate immune response to infection. Herein, we review the structure, function, regulation, and virulence characteristics of the T3SS effector ExoU, a highly cytotoxic phospholipase A 2 enzyme.
Keyphrases
- type iii
- innate immune
- pseudomonas aeruginosa
- gram negative
- escherichia coli
- cystic fibrosis
- biofilm formation
- multidrug resistant
- single cell
- cell therapy
- end stage renal disease
- newly diagnosed
- acinetobacter baumannii
- ejection fraction
- healthcare
- staphylococcus aureus
- oxidative stress
- stem cells
- respiratory failure
- patient reported outcomes
- regulatory t cells
- intensive care unit
- dendritic cells
- electronic health record
- community acquired pneumonia
- patient reported